Literature DB >> 16298369

Malonyl-CoA decarboxylase is present in the cytosolic, mitochondrial and peroxisomal compartments of rat hepatocytes.

Erik Joly1, Moise Bendayan, Raphaël Roduit, Asish K Saha, Neil B Ruderman, Marc Prentki.   

Abstract

A role for cytosolic malonyl-CoA decarboxylase (MCD) as a regulator of fatty acid oxidation has been postulated. However, there is no direct evidence that MCD is present in the cytosol. To address this issue, we performed cell fractionation and electron microscopic colloidal gold studies of rat liver to determine the location and activity of MCD. By both methods, substantial amounts of MCD protein and activity were found in the cytosol, mitochondria and peroxisomes, the latter with the highest specific activity. MCD species with different electrophoretic mobility were observed in the three fractions. The data demonstrate that active MCD is present in the cytosol, mitochondria and peroxisomes of rat liver, consistent with the view that MCD participates in the regulation of cytosolic malonyl-CoA levels and of hepatic fatty acid oxidation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16298369     DOI: 10.1016/j.febslet.2005.10.050

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  6 in total

1.  Structural asymmetry and disulfide bridges among subunits modulate the activity of human malonyl-CoA decarboxylase.

Authors:  David Aparicio; Rosa Pérez-Luque; Xavier Carpena; Mireia Díaz; Joan C Ferrer; Peter C Loewen; Ignacio Fita
Journal:  J Biol Chem       Date:  2013-03-11       Impact factor: 5.157

2.  Clinical, enzymatic and molecular characterization of nine new patients with malonyl-coenzyme A decarboxylase deficiency.

Authors:  G S Salomons; C Jakobs; L Landegge Pope; A Errami; M Potter; M Nowaczyk; S Olpin; N Manning; J A J Raiman; T Slade; M P Champion; D Peck; D Gavrilov; R Hillman; G E Hoganson; K Donaldson; J P H Shield; D Ketteridge; M Wasserstein; K M Gibson
Journal:  J Inherit Metab Dis       Date:  2006-12-20       Impact factor: 4.982

3.  AMPK phosphorylation of ACC2 is required for skeletal muscle fatty acid oxidation and insulin sensitivity in mice.

Authors:  Hayley M O'Neill; James S Lally; Sandra Galic; Melissa Thomas; Paymon D Azizi; Morgan D Fullerton; Brennan K Smith; Thomas Pulinilkunnil; Zhiping Chen; M Constantine Samaan; Sebastian B Jorgensen; Jason R B Dyck; Graham P Holloway; Thomas J Hawke; Bryce J van Denderen; Bruce E Kemp; Gregory R Steinberg
Journal:  Diabetologia       Date:  2014-06-10       Impact factor: 10.122

4.  Pioglitazone stimulates AMP-activated protein kinase signalling and increases the expression of genes involved in adiponectin signalling, mitochondrial function and fat oxidation in human skeletal muscle in vivo: a randomised trial.

Authors:  D K Coletta; A Sriwijitkamol; E Wajcberg; P Tantiwong; M Li; M Prentki; M Madiraju; C P Jenkinson; E Cersosimo; N Musi; R A Defronzo
Journal:  Diabetologia       Date:  2009-01-24       Impact factor: 10.122

5.  Crystal structures of malonyl-coenzyme A decarboxylase provide insights into its catalytic mechanism and disease-causing mutations.

Authors:  D Sean Froese; Farhad Forouhar; Timothy H Tran; Melanie Vollmar; Yi Seul Kim; Scott Lew; Helen Neely; Jayaraman Seetharaman; Yang Shen; Rong Xiao; Thomas B Acton; John K Everett; Giuseppe Cannone; Sriharsha Puranik; Pavel Savitsky; Tobias Krojer; Ewa S Pilka; Wasim Kiyani; Wen Hwa Lee; Brian D Marsden; Frank von Delft; Charles K Allerston; Laura Spagnolo; Opher Gileadi; Gaetano T Montelione; Udo Oppermann; Wyatt W Yue; Liang Tong
Journal:  Structure       Date:  2013-06-20       Impact factor: 5.006

6.  A novel frameshift mutation of malonyl-CoA decarboxylase deficiency: clinical signs and therapy response of a late-diagnosed case.

Authors:  Melike Ersoy; Mehmet Bedir Akyol; Serdar Ceylaner; Nihan Çakır Biçer
Journal:  Clin Case Rep       Date:  2017-06-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.